The Food and Drug Administration is ramping up technology adoption, and prioritizing AI and data strategies to ensure safety of new interventions and medical devices, improve workflows and ultimately deliver on its public health mission. Arunan Skandarajah, an FDA Presidential Innovation Fellow who believes in the power of equitable digital tools, discusses how he is innovating FDA’s regulatory processes to drive greater efficiencies.
HealthCast
Season 2
Episode 30
36m listen
How AI, Data Are Boosting FDA’s Regulatory Processes
Share
A Presidential Innovation Fellow is helping the agency improve workflows and ultimately ensure safety of the drugs and treatments it regulates.
-
Arunan Skandarajah Presidential Innovation Fellow FDA
Related Content
-
Agencies Seek Faster Cloud Adoption, Control Over IT Costs
New tools, faster contracting and automated compliance are helping agencies address challenges in modernizing legacy systems.
2m read -
The Cybersecurity Nightmares Threatening Modern Organizations
Cybersecurity leaders examine the hidden threats facing organizations, from shadow AI and legacy systems to alert fatigue, analyst burnout and emerging AI risks.
17m watch -
Army's Project Gatekeeper Platform to Launch This Month
Acting Army CIO Gabe Chiulli said the service’s new DevSecOps platform designed to more efficiently engage industry will debut on Oct. 23.
3m read -
AI Adoption Pushes Agencies to Rethink Infrastructure, Costs
Federal technology leaders are prioritizing flexible infrastructure, cost management and human oversight as AI takes on more complex tasks.
3m read
